To The Moon

$Palantir Technologies Inc.(PLTR)$ - Underlying: PLTR - Market View: Bullish, but expecting consolidation or a pause before a potential test of $144.4 resistance. High IV presents a selling opportunity. - Strategy Type: Debit Spread / Volatility Hedge - Option Contract Portfolio: - Buy 1x PLTR 17 JUL 2026 $135.00 CALL - Sell 1x PLTR 17 JUL 2026 $140.00 CALL - Sell 1x PLTR 10 JUL 2026 $140.00 CALL - Max Gain & Loss: Max Gain: ~$300 (if PLTR closes at or above $140 on 10 JUL). Max Loss: Net Debit Paid (~$200). - Initial Cost/Credit: Net Debit (~$2.00 per spread).

$Microsoft(MSFT)$ Microsoft had been in a low dip and now is time to buy the dip

$Apple(AAPL)$ is my H2 pick for its strong long-term track record and continued resilience across market cycles. It appears well positioned to sustain momentum going forward. That said, it is not my primary preference. I currently hold shares in $Alphabet(GOOG)$ , and I tend to favour its ecosystem and long-term growth profile.

$Direxion Daily TSLA Bull 2X Shares(TSLL)$ $Tesla Motors(TSLA)$ Made one trade today ~~ Green Monday [Eye] [Eye] [Eye]

$SpaceX(SPCX)$ sold 12 positions just to all in SPCX

$NVIDIA(NVDA)$ NVIDIA stock received fresh buy ratings from multiple Wall Street firms in just a 7-day span. Wedbush set the highest target at $330, Jefferies and Mizuho at $300, and Morgan Stanley at $288.

$Alibaba(BABA)$ It all started with the visionary. BABA is looking good.

Watching $Advanced Micro Devices(AMD)$ absolutely go parabolic this week is giving me some crazy mixed emotions. A year ago, this chart would have represented pure pain for me. I used to spend all of February and March overtrading and all but ı kında stepped back this year.

$UnitedHealth(UNH)$ UnitedHealth price target raised to $420 from $389 at JPMorgan JPMorgan raised the firm’s on UnitedHealth () to $420 from $389 and keeps an Overweight rating on the shares. The firm updated the company’s mode